Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Brainsway Ltd (BRIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6610
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It offers deep TMS that used for treatment of depressive episodes in adult patients suffering from depressive disorder. Brainsway conducts various clinical research programs. The company also operates online portals for patients, physicians and researchers, among others. It partners with various institutions and researchers in clinical trials covering various neuropsychiatric, neuroscience applications, and others. The company operates in Israel. Brainsway is headquartered in Jerusalem, Israel.

Brainsway Ltd (BRIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Ltd, Medical Equipment, Deal Details 10
Private Equity 10
Brainsway Raises USD8.5 Million in Financing 10
Partnerships 11
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Equity Offering 14
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd – Key Competitors 17
Brainsway Ltd – Key Employees 18
Brainsway Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 27, 2018: Brainsway announces financial results for second quarter of 2018 20
May 29, 2018: Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update 22
Mar 19, 2018: Brainsway Announces Fourth Quarter and Full-Year 2017 Financial Results 23
Nov 20, 2017: Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017 24
Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 25
Corporate Communications 26
Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry 26
Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO 27
Other Significant Developments 28
Jul 10, 2018: Sandhya Prashad, M.D., Now Offering BrainsWay Deep TMS to Patients With Depression in Houston Area 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Brainsway Ltd, Medical Equipment, Key Facts, 2017 2
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Deals By Market, 2012 to YTD 2018 8
Brainsway Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Brainsway Raises USD8.5 Million in Financing 10
Medison Pharma Enters into Marketing and Distribution Agreement with Brainsway 11
Brainsway Enters into Distribution Agreement with Moksha8 Pharma 12
Brainsway Enters Into Co-Marketing Agreement For Deep TMS System 13
Brainsway Completes Private Placement Of Shares For US$11.8 Million 14
Brainsway Completes Public Offering Of Shares For US$6.7 Million 15
Brainsway Raises USD1 Million in Private Placement of Shares 16
Brainsway Ltd, Key Competitors 17
Brainsway Ltd, Key Employees 18
Brainsway Ltd, Subsidiaries 19

List of Figures
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Brainsway Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Brainsway Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Brainsway Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Brainsway Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Protea Biosciences Group Inc (PRGB)-医療機器分野:企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Fibria Celulose S.A.:企業の戦略・SWOT・財務情報
    Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report Summary Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Hackett Group, Inc. (HCKT):企業の財務・戦略的SWOT分析
    The Hackett Group, Inc. (HCKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …
  • Generex Biotechnology Corp (GNBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Mayo Clinic:製薬・医療:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Epiroc AB (EPI A):企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • 1-800 Contacts Inc:医療機器:M&Aディール及び事業提携情報
    Summary 1-800 Contacts Inc (1-800 Contacts) is a medical device company that markets contact lenses. The company provides various contact lens types such as vial contact lenses, disposable contact lenses, multifocal or bifocal lenses, toric or astigmatism lenses, color and enhancing lenses, and othe …
  • Echo Therapeutics Inc (ECTE)-医療機器分野:企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Barton Malow Company:企業の戦略・SWOT・財務情報
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Brake Bros Foodservice Limited:企業の戦略・SWOT・財務分析
    Brake Bros Foodservice Limited - Strategy, SWOT and Corporate Finance Report Summary Brake Bros Foodservice Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Bank of Yokohama Ltd:企業の戦略・SWOT・財務分析
    The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pernix Therapeutics Holdings Inc (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • P2 Energy Solutions Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary P2 Energy Solutions Inc (P2 Energy), a subsidiary of P2ES Holdings Inc, is an oilfield services company that develops and offers oilfield software solutions. The company provides various tools for environmental, health and safety, finance and accounting, land management and geospatial data, …
  • Apache Corporation:企業の戦略・SWOT・財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Compugen Ltd (CGEN):企業の財務・戦略的SWOT分析
    Summary Compugen Ltd (Compugen) is a predictive drug discovery and development company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises COM701 and PVRIG, BAY 1905254, COM902 and TIGIT; and CGEN-XXXX/Myeloid and autoimmune diseases …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆